Literature DB >> 16390896

Continuity of antidepressant treatment for adults with depression in the United States.

Mark Olfson1, Steven C Marcus, Michael Tedeschi, George J Wan.   

Abstract

OBJECTIVE: Continuation of antidepressant treatment for depression beyond the first months helps to consolidate treatment response and to reduce the risk of early relapse. The authors sought to characterize the rate and pattern of antidepressant discontinuation among adults initiating antidepressant treatment for depression.
METHOD: Data were drawn from the household component of the Medical Expenditure Panel Survey for 1996-2001. Analysis was limited to data for adults age 18 years and older (N=829) who initiated antidepressant treatment for depression and who 1) discontinued treatment during the first 30 days of treatment, 2) completed the first 30 days of treatment and then discontinued treatment during the following 60 days, or 3) continued treatment for more than 90 days after treatment initiation.
RESULTS: A majority of the patients discontinued antidepressant therapy during the first 30 days (42.4%). Only 27.6% of the patients continued antidepressant therapy for more than 90 days. Antidepressant discontinuation during the first 30 days of treatment was significantly more common among Hispanics (53.8%) than non-Hispanics (41.3%); patients with fewer than 12 years of education (50.8%), compared with those with 12 or more years (39.3%); and patients with low family incomes (50.2%), compared with those with medium or high family incomes (38.6%). Patients were significantly more likely to continue antidepressant treatment beyond 30 days if they received psychotherapy (68.0% versus 43.7%), completed 12 or more years of education (64.8% versus 52.0%), or had private health insurance (60.1% versus 50.8%). Among those who continued antidepressants beyond 30 days, antidepressant continuity during the subsequent 60 days was significantly associated with fair or poor pretreatment self-rated mental health and physical health, treatment with a selective serotonin reuptake inhibitor or serotonin-norepinephrine reuptake inhibitor, and psychotherapy.
CONCLUSIONS: Early discontinuation of antidepressant therapy is widespread in the community treatment of depression, especially among socioeconomically disadvantaged patients. Provision of psychotherapy and selection of an appropriate antidepressant medication may reduce the risk of discontinuation during the first 3 months of antidepressant treatment for depression.

Entities:  

Mesh:

Substances:

Year:  2006        PMID: 16390896     DOI: 10.1176/appi.ajp.163.1.101

Source DB:  PubMed          Journal:  Am J Psychiatry        ISSN: 0002-953X            Impact factor:   18.112


  125 in total

1.  Vitamin D and depression: where is all the sunshine?

Authors:  Sue Penckofer; Joanne Kouba; Mary Byrn; Carol Estwing Ferrans
Journal:  Issues Ment Health Nurs       Date:  2010-06       Impact factor: 1.835

2.  Evaluation of a fotonovela to increase depression knowledge and reduce stigma among Hispanic adults.

Authors:  Jennifer B Unger; Leopoldo J Cabassa; Gregory B Molina; Sandra Contreras; Melvin Baron
Journal:  J Immigr Minor Health       Date:  2013-04

3.  Adaptation of a motivational interviewing intervention to improve antidepressant adherence among Latinos.

Authors:  Alejandro Interian; Igda Martinez; Lisbeth Iglesias Rios; Jonathan Krejci; Peter J Guarnaccia
Journal:  Cultur Divers Ethnic Minor Psychol       Date:  2010-04

4.  Depression in primary care: encouragement and caution for the business case.

Authors:  Christopher M Callahan
Journal:  J Gen Intern Med       Date:  2006-10       Impact factor: 5.128

5.  A qualitative analysis of the perception of stigma among Latinos receiving antidepressants.

Authors:  Alejandro Interian; Igda E Martinez; Peter J Guarnaccia; William A Vega; Javier I Escobar
Journal:  Psychiatr Serv       Date:  2007-12       Impact factor: 3.084

6.  Evaluation of a Clinical Pharmacist-Led Multidisciplinary Antidepressant Telemonitoring Service in the Primary Care Setting.

Authors:  Shubha Bhat; Miranda E Kroehl; Katy E Trinkley; Zeta Chow; Lauren J Heath; Sarah J Billups; Danielle F Loeb
Journal:  Popul Health Manag       Date:  2017-12-06       Impact factor: 2.459

Review 7.  Psychotropic medication nonadherence among United States Latinos: a comprehensive literature review.

Authors:  Nicole M Lanouette; David P Folsom; Andres Sciolla; Dilip V Jeste
Journal:  Psychiatr Serv       Date:  2009-02       Impact factor: 3.084

8.  Cost-Effectiveness of a Technology-Facilitated Depression Care Management Adoption Model in Safety-Net Primary Care Patients with Type 2 Diabetes.

Authors:  Joel W Hay; Pey-Jiuan Lee; Haomiao Jin; Jeffrey J Guterman; Sandra Gross-Schulman; Kathleen Ell; Shinyi Wu
Journal:  Value Health       Date:  2017-12-06       Impact factor: 5.725

9.  Antidepressant adherence after psychiatric hospitalization among VA patients with depression.

Authors:  Kara Zivin; Dara Ganoczy; Paul N Pfeiffer; Erin M Miller; Marcia Valenstein
Journal:  Adm Policy Ment Health       Date:  2009-07-16

Review 10.  Biomarkers to predict antidepressant response.

Authors:  Andrew F Leuchter; Ian A Cook; Steven P Hamilton; Katherine L Narr; Arthur Toga; Aimee M Hunter; Kym Faull; Julian Whitelegge; Anne M Andrews; Joseph Loo; Baldwin Way; Stanley F Nelson; Steven Horvath; Barry D Lebowitz
Journal:  Curr Psychiatry Rep       Date:  2010-12       Impact factor: 5.285

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.